Sandoz - A Novartis Company
Patients are our priority and at the heart of our work here at Sandoz. Each day, we work together to help create a healthier world in which everyone has access to the medicines they need, no matter who or where they are.
Sandoz anti-TB products
Sandoz has a wide range of product portfolio of Rifampicin based finished dose formulations. These include fixed dose combinations, combi-packs and individual drugs, which have been developed in line with treatment guidelines of WHO and other National TB control programmes
Tuberculosis
Tuberculosis, commonly known as TB is curable and preventable disease; yet every minute, someone is infected with TB. Early detection and taking full course of treatment with standardized anti- TB drugs can help cure TB.
SPIRITUS
SPRITUS, the in-house scientific journal developed by Sandoz provides the contemporary information in the area of tuberculosis to TB physicians. SPIRITUS contains scientific updates from WHO and other organizations, published and contributed articles by TB experts around the world.
Novartis TB Drug Donation
From 2005 to 2012, Novartis has donated nearly 500,000 TB treatments to Tanzania. This donation is made available through the Global Drug Facility (GDF) of the Stop TB Partnership, which is hosted by the World Health Organization.
Manufacturing Capabilities
Sandoz is a WHO prequalified manufacturer of anti- TB drugs. Sandoz supplies its high quality anti- TB drugs to WHO and other National TB programmes from its state of the art dedicated manufacturing capacities for Rifampicin based formulations based in in India.
